95 related articles for article (PubMed ID: 32268374)
1. Keep taking your ACE inhibitors and ARBs during the COVID 19 pandemic.
Speth RC
J Travel Med; 2020 May; 27(3):. PubMed ID: 32268374
[No Abstract] [Full Text] [Related]
2. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
[TBL] [Abstract][Full Text] [Related]
3. Controversy regarding ACE inhibitors / ARBs in COVID-19.
Soria Arcos F; Romero Puche A; Vicente Vera T
Rev Esp Cardiol (Engl Ed); 2020 Jun; 73(6):516. PubMed ID: 32371022
[No Abstract] [Full Text] [Related]
4. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.
Zhou F; Liu YM; Xie J; Li H; Lei F; Yang H; Qin JJ; Cai J; Zhang XJ; Wu B; Xia M; Xiang D; Yang C; Ma X; Xu Q; Lu Z; Lu H; Xia X; Wang D; Liao X; Peng G; Yang J; Huang X; Zhang BH; Yuan Y; Wei X; Liu PP; Wang Y; Zhang P; She ZG; Xia J; Li H
Hypertension; 2020 Aug; 76(2):e15-e17. PubMed ID: 32493070
[No Abstract] [Full Text] [Related]
5. Reply: ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19.
Amat-Santos IJ; Santos-Martinez S; López-Otero D; Delgado-Arana JR; San Román JA
J Am Coll Cardiol; 2020 Oct; 76(17):2042. PubMed ID: 33092743
[No Abstract] [Full Text] [Related]
6. Commentary on "angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic".
Ferrario CM
Diabetes Metab Syndr; 2020; 14(5):1401-1402. PubMed ID: 32755842
[No Abstract] [Full Text] [Related]
7. ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19.
Wang Y; Tse G; Li G; Lip GYH; Liu T
J Am Coll Cardiol; 2020 Oct; 76(17):2041. PubMed ID: 33092742
[No Abstract] [Full Text] [Related]
8. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
[TBL] [Abstract][Full Text] [Related]
9. Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe COVID-19?
Aamodt AH; Bjørk MH; Tronvik EA; Buanes EA; Stovner LJ; Atar D
Tidsskr Nor Laegeforen; 2020 Jun; 140(9):. PubMed ID: 32549022
[No Abstract] [Full Text] [Related]
10. COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy.
Kussmaul WG
Ann Intern Med; 2020 Aug; 173(3):237-238. PubMed ID: 32422077
[TBL] [Abstract][Full Text] [Related]
11. Observational data during the COVID-19 pandemic: opportunity with uncertainty.
Straw S; Witte KK
Heart; 2020 Oct; 106(19):1461-1462. PubMed ID: 32759292
[No Abstract] [Full Text] [Related]
12. Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?
Selçuk M; Çınar T; Keskin M; Çiçek V; Kılıç Ş; Kenan B; Doğan S; Asal S; Günay N; Yıldırım E; Keskin Ü; Orhan AL
Clin Exp Hypertens; 2020 Nov; 42(8):738-742. PubMed ID: 32569491
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
[TBL] [Abstract][Full Text] [Related]
14. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment.
De Cauwer H
Intern Emerg Med; 2020 Nov; 15(8):1581-1582. PubMed ID: 32564289
[No Abstract] [Full Text] [Related]
15. A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).
Talreja H; Tan J; Dawes M; Supershad S; Rabindranath K; Fisher J; Valappil S; van der Merwe V; Wong L; van der Merwe W; Paton J
N Z Med J; 2020 Apr; 133(1512):85-87. PubMed ID: 32242182
[TBL] [Abstract][Full Text] [Related]
16. Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
Kansagara D; Mackey K; Vela K
Ann Intern Med; 2020 Aug; 173(3):W66. PubMed ID: 32584593
[No Abstract] [Full Text] [Related]
17. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.
Diaz JH
J Travel Med; 2020 May; 27(3):. PubMed ID: 32186711
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Guo J; Huang Z; Lin L; Lv J
J Am Heart Assoc; 2020 Apr; 9(7):e016219. PubMed ID: 32233755
[No Abstract] [Full Text] [Related]
19. Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).
Thomas LE; Bonow RO; Pencina MJ
JAMA Cardiol; 2020 Sep; 5(9):988-990. PubMed ID: 32936260
[No Abstract] [Full Text] [Related]
20. Response to "COVID-19 and ACEI/ARB: Not Associated?".
Schiffrin EL; Flack JM; Ito S; Muntner P; Webb RC
Am J Hypertens; 2020 Aug; 33(8):789-790. PubMed ID: 32415836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
